Food-effect Bioavailability of Fixed Dose Combination Zemimet® SR Tab. 50/1000 mg Under Fed and Fasting Conditions

NCT04070794 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: Gemigliptin/Metformin Hydrochloride Sustained Release 50/1000 mg(Fasting)
DRUG: Gemigliptin/Metformin Hydrochloride Sustained Release 50/1000 mg(Fed)

Sponsor

LG Chem